{"filing":{"accession_number":"0001104659-26-107485","cik":"0001566044","ticker":"VYNE","company_name":"Yarrow Bioscience, Inc.","form":"8-K","filing_date":"2026-09-14","report_date":"2026-09-10","primary_document":"tm2624918d3_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1566044/000110465926107485/tm2624918d3_8k.htm"},"events":[{"id":33245,"run_id":30566,"accession_number":"0001104659-26-107485","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Yarrow Bioscience entered into an underwriting agreement on September 10, 2026 to issue and sell 5,769,231 shares of common stock at $26.00 per share, with underwriters exercising a full option for an additional 865,384 shares. The offering is expected to raise approximately $161.8 million in net proceeds. This is a registered public offering of equity securities that will dilute existing shareholders and materially affect the company's capital structure and share count.","company_name":"Yarrow Bioscience, Inc.","ticker":"VYNE","filing_date":"2026-09-14","form":"8-K","submitted_at":null,"items":[{"id":36640,"accession_number":"0001104659-26-107485","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Yarrow Bioscience entered into an underwriting agreement on September 10, 2026 to issue and sell 5,769,231 shares of common stock at $26.00 per share, with underwriters exercising a full option for an additional 865,384 shares. The offering is expected to raise approximately $161.8 million in net proceeds. This is a registered public offering of equity securities that will dilute existing shareholders and materially affect the company's capital structure and share count.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-14T20:03:07.792108+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":36640,"accession_number":"0001104659-26-107485","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Yarrow Bioscience entered into an underwriting agreement on September 10, 2026 to issue and sell 5,769,231 shares of common stock at $26.00 per share, with underwriters exercising a full option for an additional 865,384 shares. The offering is expected to raise approximately $161.8 million in net proceeds. This is a registered public offering of equity securities that will dilute existing shareholders and materially affect the company's capital structure and share count.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-14T20:03:07.792108+00:00","company_name":"Yarrow Bioscience, Inc.","ticker":"VYNE","filing_date":"2026-09-14"}]}